US · Healthcare

UCB SA ADR (UCBJY)

Biotechnology

UCB SA ADR (UCBJY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for UCBJY

P/E ratio
18.00

UCB SA ADR (UCBJY) — FAQ

What is UCBJY's P/E ratio?

The price-to-earnings (P/E) ratio for UCB SA ADR (UCBJY) is 18.00 (data as of 2026-03-25).

Does UCB SA ADR pay a dividend?

Dividend yield is not available in the current snapshot for UCB SA ADR (UCBJY). Check the MyAverix Finance app for the latest dividend data.

What sector is UCB SA ADR in?

UCB SA ADR (UCBJY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is UCBJY listed on?

UCBJY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play